As per the filing, Biogen has a 10.2% stake in Sage Therapeutics. The offer price, representing a 30% premium to the stock's ...
(Reuters) - The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback